215 related articles for article (PubMed ID: 9890024)
1. Forty years of canine vaccination.
Appel MJ
Adv Vet Med; 1999; 41():309-24. PubMed ID: 9890024
[TBL] [Abstract][Full Text] [Related]
2. Canine viral vaccines at a turning point--a personal perspective.
Carmichael LE
Adv Vet Med; 1999; 41():289-307. PubMed ID: 9890023
[TBL] [Abstract][Full Text] [Related]
3. Theoretical and practical aspects of an immunization program for dogs and cats.
Schultz RD
J Am Vet Med Assoc; 1982 Nov; 181(10):1142-9. PubMed ID: 6294029
[No Abstract] [Full Text] [Related]
4. Experiments with a homologous, inactivated canine parvovirus vaccine in vaccination programmers for dogs.
Wilson JH; Hermann-Dekkers WM
Vet Q; 1982; 4(3):108-16. PubMed ID: 6293155
[TBL] [Abstract][Full Text] [Related]
5. Duration of serologic response to five viral antigens in dogs.
Mouzin DE; Lorenzen MJ; Haworth JD; King VL
J Am Vet Med Assoc; 2004 Jan; 224(1):55-60. PubMed ID: 14710876
[TBL] [Abstract][Full Text] [Related]
6. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
7. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
Litster A; Nichols J; Volpe A
Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
[TBL] [Abstract][Full Text] [Related]
9. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia.
Mitchell SA; Zwijnenberg RJ; Huang J; Hodge A; Day MJ
Aust Vet J; 2012 Dec; 90(12):468-73. PubMed ID: 23186088
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a killed feline panleukopenia virus vaccine against canine parvoviral enteritis in dogs.
Wierup M; Olson P; Hedhammar A; Klingeborn B; Karlsson KA
Am J Vet Res; 1982 Dec; 43(12):2183-7. PubMed ID: 6299140
[TBL] [Abstract][Full Text] [Related]
11. Field evaluation of a canine parvovirus vaccination program, using feline origin modified live virus vaccine.
Gordon JC; Rogers WA
J Am Vet Med Assoc; 1982 Jun; 180(12):1429-31. PubMed ID: 6284689
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
[TBL] [Abstract][Full Text] [Related]
13. Vaccine use and disease prevalence in dogs and cats.
Horzinek MC
Vet Microbiol; 2006 Oct; 117(1):2-8. PubMed ID: 16698198
[TBL] [Abstract][Full Text] [Related]
14. Serum antibody response to canine parvovirus, canine adenovirus-1, and canine distemper virus in dogs with known status of immunization: study of dogs in Sweden.
Olson P; Klingeborn B; Hedhammar A
Am J Vet Res; 1988 Sep; 49(9):1460-6. PubMed ID: 3223653
[TBL] [Abstract][Full Text] [Related]
15. A doggy tale: Risk of zoonotic infection with Bordetella bronchiseptica for cystic fibrosis (CF) patients from live licenced bacterial veterinary vaccines for cats and dogs.
Moore JE; Rendall JC; Millar BC
J Clin Pharm Ther; 2022 Feb; 47(2):139-145. PubMed ID: 34328230
[TBL] [Abstract][Full Text] [Related]
16. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
[TBL] [Abstract][Full Text] [Related]
17. The failure of an inactivated mink enteritis virus vaccine in four preparations to provide protection to dogs against challenge with canine parvovirus-2.
Carman S; Povey C
Can J Comp Med; 1982 Jan; 46(1):47-50. PubMed ID: 6280820
[TBL] [Abstract][Full Text] [Related]
18. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination.
Pollock RV; Carmichael LE
J Am Vet Med Assoc; 1982 Jan; 180(1):37-42. PubMed ID: 7056660
[TBL] [Abstract][Full Text] [Related]
19. Veterinary Products Committee working group report on feline and canine vaccination.
Gaskell RM; Gettinby G; Graham SJ; Skilton D
Vet Rec; 2002 Feb; 150(5):126-34. PubMed ID: 11871665
[TBL] [Abstract][Full Text] [Related]
20. Use of modified live feline panleukopenia virus vaccine to immunize dogs against canine parvovirus.
Pollock RV; Carmichael LE
Am J Vet Res; 1983 Feb; 44(2):169-75. PubMed ID: 6299142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
